ImMage Biotherapeutics

Founded in May 2015, ImMAGE Biotherapeutics Corp. is a seed-funded biotechnology company developing the first universal Immunotherapy to treat patients with an aggressive form of breast cancer called Triple NegativeBreast Cancer (TNBC).

Website :

Call 2018

The 2018 call for applications for the Young Enterprise Initiative – Start in France is now closed for Finnish, Italian, South Korean, Taiwanese, and U.S. companies. The call will open soon for South African companies.

Country Programs



Receive notifications about the YEi Start in France program (Call for applications, announcement of the laureates, YEi events, etc.)

Social Links